Saland Jeffrey M, Shneider Benjamin L, Bromberg Jonathan S, Shi Patricia A, Ward Stephen C, Magid Margret S, Benchimol Corinne, Seikaly Mouin G, Emre Sukru H, Bresin Elena, Remuzzi Giuseppe
Department of Pediatrics, The Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA.
Clin J Am Soc Nephrol. 2009 Jan;4(1):201-6. doi: 10.2215/CJN.02170508. Epub 2008 Nov 12.
A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS).
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Case report.
Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr.
This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.
一名有血栓性微血管病家族史的男婴患上了非典型溶血尿毒综合征(aHUS)。
设计、地点、参与者与测量方法:病例报告。
基因分析显示编码补体因子H(CFH)的CFH基因存在杂合突变(S1191L)。该患儿多次发生溶血尿毒综合征,每次发作均接受血浆置换治疗。随着时间推移,尽管开始了血浆置换预防性治疗方案,但其肾功能仍显著下降。4岁时,他接受了(劈离式肝脏)肝肾联合移植(LKT),术前进行了血浆置换和依诺肝素抗凝。两个移植物的初始功能均良好,并维持了近2年。
本报告增加了接受LKT治疗与CFH突变相关的aHUS并取得良好疗效的病例数量,尽管数量不多但仍在增加,扩展了使用劈离式肝脏移植物的技术,并描述了溶血尿毒综合征中亚临床肝脏疾病的独特组织学特征。